CHILE
February 14, 2016
On January 4th, 2016, a series of amendments were introduced to the bill of law that modifies the Health Code in order to regulate generic bioequivalent pharmaceutical products and prevent the vertical integration of pharmaceutical laboratories and pharmacies. Among other provisions
the bill sets forth that pharmaceutical companies that either manufacture or import products must provide the Ministry of Health and the Public Health Institute with information about the prices of the pharmaceutical products that are available for sale.